Recap: Akebia Therapeutics Q1 Earnings

Benzinga Insights

Tue, May 5, 2020, 9:38 AM1 min read

In this article:

Shares of Akebia Therapeutics (NASDAQ:AKBA) surged 24% after the company reported Q1 results.

Quarterly Results

Earnings per share fell 6.82% year over year to ($0.47), which beat the estimate of ($0.62).

Revenue of $88,478,000 up by 21.76% year over year, which beat the estimate of $77,480,000.

Looking Ahead

Akebia Therapeutics hasn't issued any earnings guidance for the time being.

Revenue guidance hasn't been issued by the company for now.

Details Of The Call

Date: May 05, 2020

View more earnings on AKBA

Time: 01:05 PM ET

Webcast URL: https://edge.media-server.com/mmc/p/tni8ok36

Price Action

52-week high: $10.53

Company's 52-week low was at $2.99

Price action over last quarter: Up 24.78%

Company Overview

Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States.

See more from Benzinga

‘Americans just work harder’ than Europeans, says CEO of Norway’s $1.6 trillion oil fund, because they have a higher ‘general level of ambition’
"We are not very ambitious. I should be careful about talking about work-life balance, but the Americans just work harder.”
Fortune•1d ago
Warren Buffett Says 'When It Rains Gold, Put Out The Bucket' And This High Yield Investment Is Making It Rain
In his 2016 letter to Berkshire Hathaway shareholders, legendary investor Warren Buffett wrote, “Every decade or so, dark clouds will fill the economic skies, and they will briefly rain gold. When downpours of that sort occur, it’s imperative that we ...
Benzinga•19h ago
If I Had to Construct a Portfolio of Just 5 ETFs, Here's Exactly What I'd Buy Right Now
It's possible to construct a winning long-term investment strategy with just low-cost index funds.
Motley Fool•4h ago
The US economy may be barrelling towards stagflation, an outcome worse than recession
As US growth shows signs of sputtering and inflation keeps rising, a re-run of the tumultuous 1970s is looking more likely.
Business Insider•10h ago
Fed's favorite inflation gauge shows price increases remained sticky in March
The March reading comes as investors have continued to scale back their expectations on when the Federal Reserve will cut interest rates in 2024, if at all.
Yahoo Finance•28m ago
1 Unstoppable Stock That Could Join Microsoft, Apple, Nvidia, Alphabet, Amazon, and Meta in the $1 Trillion Club
The combination of artificial intelligence (AI) and cybersecurity is a match made in heaven.
Motley Fool•5h ago
US inflation rises in line with expectations in March
U.S. inflation rose moderately in March, but that is unlikely to change financial markets' expectations that the Federal Reserve will hold off cutting interest rates until September. The personal consumption expenditures (PCE) price index increased 0.3% last month, the Commerce Department's Bureau of Economic Analysis said on Friday. Data for February was unrevised to show the PCE price index gaining 0.3% as previously reported.
Reuters•19m ago
Rooting for Trump to fail has made his stock shorters millions
Rooting for Donald Trump to fail has rarely been this profitable. Just ask a hardy band of mostly amateur Wall Street investors who have collectively made tens of millions of dollars over the past month by betting that the stock price of his social media business — Truth Social — will keep dropping despite massive buying by Trump loyalists and wild swings that often mirror the candidate’s latest polls, court trials and outbursts on Trump Social itself.
Associated Press Finance•9h ago
1 Unstoppable Artificial Intelligence (AI) Stock to Buy and Hold Forever
This company should continue to make millionaires, just as it has over the past two decades.
Motley Fool•2h ago
Investors brace for 5% Treasury yields as US inflation worries mount
As U.S. inflation worries grow, some investors are preparing for the 10-year U.S. Treasury yield to breach a 16-year high of 5% hit last October. Bond yields, which move inversely to prices, have climbed in recent weeks as signs of persistent inflation erode expectations for how deeply the Federal Reserve will be able to cut interest rates without further fueling consumer prices. Many investors are betting further weakness lies ahead for bonds.
Reuters•8h ago

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Recap: Akebia Therapeutics Q1 Earnings

Recommended Stories

‘Americans just work harder’ than Europeans, says CEO of Norway’s $1.6 trillion oil fund, because they have a higher ‘general level of ambition’

Warren Buffett Says 'When It Rains Gold, Put Out The Bucket' And This High Yield Investment Is Making It Rain

If I Had to Construct a Portfolio of Just 5 ETFs, Here's Exactly What I'd Buy Right Now

The US economy may be barrelling towards stagflation, an outcome worse than recession

Fed's favorite inflation gauge shows price increases remained sticky in March

1 Unstoppable Stock That Could Join Microsoft, Apple, Nvidia, Alphabet, Amazon, and Meta in the $1 Trillion Club

US inflation rises in line with expectations in March

Rooting for Trump to fail has made his stock shorters millions

1 Unstoppable Artificial Intelligence (AI) Stock to Buy and Hold Forever

Investors brace for 5% Treasury yields as US inflation worries mount